These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9409711)

  • 1. Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system.
    Koshimura I; Imai H; Hidano T; Endo K; Mochizuki H; Kondo T; Mizuno Y
    Brain Res; 1997 Oct; 773(1-2):108-16. PubMed ID: 9409711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture.
    Goto K; Mochizuki H; Hattori T; Nakamura N; Mizuno Y
    Brain Res; 1997 Apr; 754(1-2):260-8. PubMed ID: 9134983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
    Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW
    Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intranigral Mn2+ on striatal and nigral synthesis and levels of dopamine and cofactor.
    Daniels AJ; Abarca J
    Neurotoxicol Teratol; 1991; 13(5):483-7. PubMed ID: 1684634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH mRNA over-expression in rats with chronic excitotoxic striatal lesions.
    Hantraye P; Guibert B; Biguet NF; Lavergne A; Leviel V
    Neuroreport; 1994 Dec; 5(18):2621-4. PubMed ID: 7696617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions.
    Nagatsu T; Yoshida M
    Neurosci Lett; 1988 Apr; 87(1-2):178-82. PubMed ID: 2898112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
    Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
    Yoshida M; Ogawa M; Suzuki K; Nagatsu T
    Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra.
    Sonsalla PK; Manzino L; Sinton CM; Liang CL; German DC; Zeevalk GD
    Brain Res; 1997 Oct; 773(1-2):223-6. PubMed ID: 9409726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase as a target for deltamethrin in the nigrostriatal dopaminergic pathway.
    Liu GP; Ma Q; Shi N
    Biomed Environ Sci; 2006 Feb; 19(1):27-34. PubMed ID: 16673815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.
    Opacka-Juffry J; Ashworth S; Sullivan AM; Banati RB; Blunt SB
    J Neural Transm (Vienna); 1996; 103(12):1429-34. PubMed ID: 9029409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
    Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
    Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline on muscle tone, metabolism of dopamine in the striatum and tyrosine hydroxylase immunocytochemistry in the substantia nigra, in rats.
    Lorenc-Koci E; Smiałowska M; Antkiewicz-Michaluk L; Gołembiowska K; Bajkowska M; Wolfarth S
    Neuroscience; 2000; 95(4):1049-59. PubMed ID: 10682712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
    Hadjiconstantinou M; Mariani AP; Neff NH
    Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.